Stephen J. Tulipano

2022 - Stoke Therapeutics

In 2022, Stephen J. Tulipano earned a total compensation of $2.3M as Chief Financial Officer at Stoke Therapeutics, a 25% decrease compared to previous year.

Compensation breakdown

Bonus$17,210
Non-Equity Incentive Plan$154,890
Option Awards$1,697,431
Salary$436,800
Other$10,192
Total$2,316,523

Tulipano received $1.7M in option awards, accounting for 73% of the total pay in 2022.

Tulipano also received $17.2K in bonus, $154.9K in non-equity incentive plan, $436.8K in salary and $10.2K in other compensation.

Rankings

In 2022, Stephen J. Tulipano's compensation ranked 1,554th out of 5,753 executives tracked by ExecPay. In other words, Tulipano earned more than 73.0% of executives.

ClassificationRankingPercentile
All
1,554
out of 5,753
73rd
Division
Manufacturing
792
out of 3,133
75th
Major group
Chemicals And Allied Products
311
out of 1,419
78th
Industry group
Drugs
289
out of 1,320
78th
Industry
Pharmaceutical Preparations
205
out of 966
79th
Source: SEC filing on September 28, 2023.

Tulipano's colleagues

We found two more compensation records of executives who worked with Stephen J. Tulipano at Stoke Therapeutics in 2022.

2022

Edward Kaye

Stoke Therapeutics

Chief Executive Officer

2022

Barry Ticho

Stoke Therapeutics

Chief Medical Officer

News

In-depth

You may also like